Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy

Posted On 2021-06-08 14:40:16


We are pleased to have multiple experts of their respective fields review and discuss the current literature and ongoing trials combining RT and immunotherapy. After reading our edition, I hope you have a better overview of where the oncology field is heading and how together with both RT and immunotherapy, we can continue our efforts to treat and potentially cure our patients with cancer.

Editorial on Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy
Radiation and immunotherapy: united as one in the fight against cancer
Arya Amini, Tyler Robin

Review Article on Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy
Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases
Marina Moskalenko, Tyler P. Robin

Immunotherapy and radiation for high-grade glioma: a narrative review
Kareem R. Fakhoury, Douglas E. Ney, D. Ryan Ormond, Chad G. Rusthoven

Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review
Thomas J. Hayman, Aarti K. Bhatia, Krishan R. Jethwa, Melissa R. Young, Henry S. Park

A narrative review of combining radiation and immunotherapy in gastroesophageal cancers
Kevin Yoon, Yi-Jen Chen, Joseph Chao

The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review
John H. Heinzerling, Kathryn F. Mileham, Charles B. Simone II

Combination radiation and immunotherapy in gynecologic malignancies—a comprehensive review
Colton Ladbury, Elizabeth Germino, Jennifer Novak, Jason Liu, Zachary Horne, Brandon Dyer, Scott Glaser

Narrative review of immunotherapy and radiation therapy in elderly patients
Brittney Chau, Jonnby LaGuardia, Caressa Hui, Linda Ye, Yan Xing, Erminia Massarelli, Arya Amini

Disclosure:
The focused series “Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Arya Amini and Tyler Robin are serving as the unpaid Guest Editors for the focused series.